ADC Therapeutics
ADCT
#9252
Rank
ยฃ0.10 B
Marketcap
ยฃ0.86
Share price
-5.74%
Change (1 day)
-64.62%
Change (1 year)

Revenue for ADC Therapeutics (ADCT)

Revenue in 2026 (TTM): ยฃ58.8 Million

According to ADC Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ59.43 Million. In 2025 the company made a revenue of ยฃ60.41 Million an increase over the revenue in the year 2024 that were of ยฃ56.44 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ADC Therapeutics from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ58.8 M-2.66%
2025 ยฃ60.41 M7.02%
2024 ยฃ56.44 M3.39%
2023 ยฃ54.59 M-68.53%
2022 ยฃ0.17 B590.53%
2021 ยฃ25.12 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA